Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Refusing to TAP out: 16 new human TEIPPs identified.

Gigoux M, Wolchok J.

J Exp Med. 2018 Sep 3;215(9):2233-2234. doi: 10.1084/jem.20181512. Epub 2018 Aug 21.

PMID:
30131364
2.

Lysis-independent potentiation of immune checkpoint blockade by oncolytic virus.

Oseledchyk A, Ricca JM, Gigoux M, Ko B, Redelman-Sidi G, Walther T, Liu C, Iyer G, Merghoub T, Wolchok JD, Zamarin D.

Oncotarget. 2018 Jun 19;9(47):28702-28716. doi: 10.18632/oncotarget.25614. eCollection 2018 Jun 19.

3.

PD-L1 in tumor microenvironment mediates resistance to oncolytic immunotherapy.

Zamarin D, Ricca JM, Sadekova S, Oseledchyk A, Yu Y, Blumenschein WM, Wong J, Gigoux M, Merghoub T, Wolchok JD.

J Clin Invest. 2018 Apr 2;128(4):1413-1428. doi: 10.1172/JCI98047. Epub 2018 Mar 5.

4.

CrosstalkNet: A Visualization Tool for Differential Co-expression Networks and Communities.

Manem V, Adam GA, Gruosso T, Gigoux M, Bertos N, Park M, Haibe-Kains B.

Cancer Res. 2018 Apr 15;78(8):2140-2143. doi: 10.1158/0008-5472.CAN-17-1383. Epub 2018 Feb 19.

PMID:
29459407
5.

Identification of Interacting Stromal Axes in Triple-Negative Breast Cancer.

Saleh SMI, Bertos N, Gruosso T, Gigoux M, Souleimanova M, Zhao H, Omeroglu A, Hallett MT, Park M.

Cancer Res. 2017 Sep 1;77(17):4673-4683. doi: 10.1158/0008-5472.CAN-16-3427. Epub 2017 Jun 26.

6.

Miz-1 regulates translation of Trp53 via ribosomal protein L22 in cells undergoing V(D)J recombination.

Rashkovan M, Vadnais C, Ross J, Gigoux M, Suh WK, Gu W, Kosan C, Möröy T.

Proc Natl Acad Sci U S A. 2014 Dec 16;111(50):E5411-9. doi: 10.1073/pnas.1412107111. Epub 2014 Dec 2.

7.

Dynamic reprogramming of signaling upon met inhibition reveals a mechanism of drug resistance in gastric cancer.

Lai AZ, Cory S, Zhao H, Gigoux M, Monast A, Guiot MC, Huang S, Tofigh A, Thompson C, Naujokas M, Marcus VA, Bertos N, Sehat B, Perera RM, Bell ES, Page BD, Gunning PT, Ferri LE, Hallett M, Park M.

Sci Signal. 2014 Apr 22;7(322):ra38. doi: 10.1126/scisignal.2004839.

PMID:
24757178
8.

Inducible costimulator facilitates T-dependent B cell activation by augmenting IL-4 translation.

Gigoux M, Lovato A, Leconte J, Leung J, Sonenberg N, Suh WK.

Mol Immunol. 2014 May;59(1):46-54. doi: 10.1016/j.molimm.2014.01.008. Epub 2014 Jan 31.

PMID:
24486724
9.

Phosphatidylinositol 3-kinase-independent signaling pathways contribute to ICOS-mediated T cell costimulation in acute graft-versus-host disease in mice.

Li J, Heinrichs J, Leconte J, Haarberg K, Semple K, Liu C, Gigoux M, Kornete M, Piccirillo CA, Suh WK, Yu XZ.

J Immunol. 2013 Jul 1;191(1):200-7. doi: 10.4049/jimmunol.1203485. Epub 2013 May 31.

10.

Anti-chlamydial Th17 responses are controlled by the inducible costimulator partially through phosphoinositide 3-kinase signaling.

Gao X, Gigoux M, Yang J, Leconte J, Yang X, Suh WK.

PLoS One. 2012;7(12):e52657. doi: 10.1371/journal.pone.0052657. Epub 2012 Dec 20.

11.

Inducible costimulator promotes helper T-cell differentiation through phosphoinositide 3-kinase.

Gigoux M, Shang J, Pak Y, Xu M, Choe J, Mak TW, Suh WK.

Proc Natl Acad Sci U S A. 2009 Dec 1;106(48):20371-6. doi: 10.1073/pnas.0911573106. Epub 2009 Nov 13.

Supplemental Content

Loading ...
Support Center